Elevar Therapeutics’ Global Licensing Agreement with Relay Therapeutics

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Elevar Therapeutics in the transaction, and Goodwin Procter advised Relay Therapeutics.Elevar Therapeutics, Inc. (Elevar), a majority-owned subsidiary of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here